Which immunotherapy companies will be around in 2028?
Basic
8
Ṁ1592028
1D
1W
1M
ALL
62%
Wyndly
60%
Curex
59%
Nectar
I'm trying to pick a provider for at-home sublingual immunotherapy (SLIT), but it takes up to four years to finish and I'm worrying about a startup going out of business or being acquired and no longer offering immunotherapy.
Curex:
founded 2020
can't find funding info
Wyndly:
founded 2020
2mil funding in 2023
yc W21 company
Nectar:
founded 2021
24mil total raised, series a
This question is managed and resolved by Manifold.
Get
1,000and
3.00
1,0003.00Related questions
Related questions
Will Immunovant agree to be acquired by the end of 2024?
17% chance
Can we cure at least one autoimmune disease in humans by 2028?
46% chance
Which of these protein targets will have at least one new drug targeting them receive FDA approval between 2025 and 2030
If I get immunotherapy from a startup, will it turn out to be a good idea?
Of the companies which are currently #11-20 in market cap, will any be larger than Eli Lilly (#10) at the end of 2024?
64% chance
Which biotech scaleup will have the largest market cap in 2030?
Will I get exosome infusions in 2024?
37% chance
Will FDA approve any mRNA vaccine against melanoma before 2028?
49% chance
Will a publicly listed pharma company reach $1T in market cap before 2025?
14% chance
Will we get a cure for cancer before 2038?
36% chance